The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer

被引:25
|
作者
Chen, Sufeng [1 ]
Zhang, Jie [1 ]
Li, Xuebing [2 ]
Luo, Xiaoyang [1 ]
Fang, Jing [2 ]
Chen, Haiquan [1 ]
机构
[1] Fudan Univ, Canc Hosp, Inst Canc, Dept Thorac Surg, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
Apoptosis; Bax; Bcl-2; Non-small cell lung cancer; Prolyl hydroxylases; HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; HIF; PROTEIN; APOPTOSIS; FAMILY; ACTIVATION; PHYSIOLOGY; ALPHA; PHD3;
D O I
10.1007/s11010-011-0976-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prolyl hydroxylase domain enzymes (PHDs) play the most notable role in cellular oxygen sensing and oxygen homeostasis, the transcription of PHD genes are involved in the protection against hypoxia and oxidative stress. Intratumoral hypoxia exists in malignant solid tumors primarily due to rapid cancer cell proliferation with high metabolic demands and defective structural and functional vasculature. Previous studies have demonstrated that all the three PHDs have the ability to hydroxylate hypoxia inducible factor (HIF) polypeptides, which are the key molecules in maintaining the oxygen homeostasis. However, PHDs play multiple physiological and pathological roles. There is scant data regarding expression of PHDs genes in non-small cell lung cancer (NSCLC) tissues. In Addition, the relationship between PHDs and apoptosis has never been explored in NSCLC. In this article, we examined the expression of PHD genes and their relationship with the tumor behavior and apoptosis-associated factors in NSCLC. Our results indicated that the expression of PHDs was much higher in lung cancer tissue than that of adjacent normal tissue, and the high expression of PHD3 was associated with early tumor stage and well differentiation in NSCLC. Moreover, increased PHD3 expression was significantly correlated with the low expression of Bcl-2, suggesting its potential role in inducing apoptosis.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 50 条
  • [1] The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer
    Sufeng Chen
    Jie Zhang
    Xuebing Li
    Xiaoyang Luo
    Jing Fang
    Haiquan Chen
    Molecular and Cellular Biochemistry, 2011, 358 : 257 - 263
  • [2] Telomerase activity and Bcl-2 expression in non-small cell lung cancer
    Ohmura, Y
    Aoe, M
    Andou, A
    Shimizu, N
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 2980 - 2987
  • [3] BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer
    Renouf, Daniel J.
    Wood-Baker, Richard
    Ionescu, Diana N.
    Leung, Samuel
    Masoudi, Hamid
    Gilks, Cyril B.
    Laskin, Janessa
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 486 - 491
  • [4] The association of BCL-2 expression with clinicopathological parameters and prognosis in non-small cell lung cancer
    Aktas, Kervankaya Selma
    Mutluay, Neslihan
    Demirag, Funda
    Koksal, Deniz
    Basay, Nihal
    Bayiz, Hulya
    Berktas, Bahadir
    Berkoglu, Mine
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S912 - S912
  • [5] Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer
    GaO, Qin
    Yang, Sheng
    Kang, Ming-Qiang
    MOLECULAR MEDICINE REPORTS, 2012, 5 (06) : 1409 - 1414
  • [6] Expression of Her-2/neu and Bcl-2 in patients with non-small cell lung cancer
    Poposka, Biljana Ilievska
    Petrusevska, Gordana
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [7] Expression of bcl-2 protein in non-small cell lung carcinoma (NSCLC)
    Athanassiadou, P
    Dosios, T
    Petrakakou, E
    Angouras, D
    Karam, B
    Kakisis, I
    Athanassiades, P
    Davaris, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1048 - 1048
  • [8] Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
    Alam, Manzar
    Alam, Shoaib
    Shamsi, Anas
    Adnan, Mohd
    Elasbali, Abdelbaset Mohamed
    Abu Al-Soud, Waleed
    Alreshidi, Mousa
    Hawsawi, Yousef MohammedRabaa
    Tippana, Anitha
    Pasupuleti, Visweswara Rao
    Hassan, Md Imtaiyaz
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer
    Yilmaz, Ayse
    Savas, Ismail
    Dizbay Sak, Serpil
    Gungor, Adem
    Kaya, Akin
    Serinsoz, Ebru
    Savas, Berna
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2005, 53 (04): : 323 - 329
  • [10] Expression of bcl-2 protein in non-small cell lung cancer: Correlation with clinicopathology and patient survival
    Laudanski, J
    Chyczewski, L
    Niklinska, WE
    Kretowska, M
    Furman, M
    Sawicki, B
    Niklinski, J
    NEOPLASMA, 1999, 46 (01) : 25 - 30